Assessing the effect of D-mannose on clinical outcome and microbiota composition in canine chronic inflammatory enteropathy

Contact: Prof. Silke Salavati, University of Edinburgh

This prospective randomised clinical trial, funded by BSAVA PetSavers, is investigating a new supplement to treat chronic inflammatory gut conditions, that could significantly reduce the amount of antibiotics or steroids used. The study looking to recruit dogs diagnosed or suspected to have chronic enteropathy (previously called inflammatory bowel disease; IBD) that are not (fully) responding to at least one well-performed elimination dietary trial. For the study, the dog’s faecal sample is required before and at the end of the 4 weeks supplementation period, to analyse the microbiota composition within it. If you would like to enrol your dog in the study, or would like more information, please email